SB92 Summary

• Establishes standards of care for persons with hemophilia and other bleeding disorders by requiring pharmacy providers distributing blood clotting products for home use to meet specified operational and quality requirements including 24-hour pharmacist availability, 24-hour shipping, and supply of all FDA-approved brands.

• Requires health insurers to provide coverage for services to persons with hemophilia and related bleeding disorders including physician services, blood clotting factor products, and diagnostic laboratory services for policies issued or renewed after the effective date.

• Mandates that Alabama-licensed physicians request medical screening for von Willebrand's disease and other bleeding disorders at a clinical coagulation laboratory before advising patients that invasive uterine surgical procedures are the most appropriate treatment for menorrhagia.

• Authorizes the Alabama Department of Public Health to compile and distribute lists of compliant home care pharmacies and adopt rules necessary to implement the act's provisions.

• Exempts the public Hemophilia Treatment Program and other programs administered by the Department of Rehabilitation Services from these requirements, with limited exceptions.